Affiliation:
1. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)
Abstract
Treatment of insomnia is an important medical and social problem due to its widespread prevalence and significant negative impact on human health. The state of chronic cerebral hyper-activation, which has cognitive, electrophysiological and metabolic manifestations, plays an important role in the development of insomnia. The sleep disorder has been proven to be a risk factor for the development of arterial hypertension, metabolic syndrome, immunodeficiency disorder and cognitive impairment. Nonmedicinal and medicinal products are used to treat insomnia. Cognitive-behavioural therapy may be effective as a psychotherapy. Non-benzodiazepine GABA-receptors agonists are most often used to treat chronic insomnia and histamine receptor blockers to treat acute insomnia among the other drugs of this group.
Reference21 articles.
1. Fitzgerald I, Donlea J, Shaw P. Waking Experience Affects Sleep Need in Drosophila. Science, 2006, 313: 1775– 1781.
2. Vivo L, Bellesi M, Marshall W, Bushong EA, Ellisman MH, Tononi G, Cirelli C. Ultrastructural evidence for synaptic scaling across the wake/sleep cycle. Science, 2017, 355: 507–510.
3. Diering G, Nirujogi R, Roth R, Worley P, Pandey A, Huganir R. Homer1a drives homeostatic scaling-down of excitatory synapses during sleep. Science, 2017, 355: 511–515.
4. Patrick Y, Lee A, Raha O et al. Effects of sleep deprivation on cognitive and physical performance in university students. Sleep Biol Rhythms, 2017, 15(3): 217–225.
5. Tsenteradze S.L., Poluektov M.G. Vliyanie narushenii sna na ravnovesie v pozhilom i starcheskom vozraste. Effektivnaya farmakoterapiya. Spetsvypusk «Son i ego rasstroistva-3», 2015, 53: 50-54.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献